Finally, our results demonstrate that HS and metabolic-related syndromes such as MetS and obesity may share transcription profiles and suggest that adipokines may be potential biomarkers for this interaction; down-regulation of ADIPOQ may be associated with diseases’ co-occurrence susceptibility. Here, ADIPOQ is linked to metabolic syndrome.